Results 111 to 120 of about 1,097,723 (197)

Immunohistochemical Expression of Tyrosine Kinase Receptors EGFR and CD117 in Canine Urothelial Carcinoma. [PDF]

Vet Sci
Files R, Nunes C, Cardoso M, Silva M, Delgado L, Prada J, Pires I.   +6 more
europepmc   +1 more source

Is asciminib an effective tyrosine kinase inhibitor for chronic myeloid leukemia patients with tyrosine kinase inhibitor resistance? [PDF]

Hematol Transfus Cell Ther
Omar MM, Alanazi MA, Jackson DE.
europepmc   +1 more source

Two-step mechanism of Bruton's tyrosine kinase membrane recruitment and activation. [PDF]

Proc Natl Acad Sci U S A
McAllister RA, Stiegler AL, Chari K, Chari M, Bhattacharyya M, Gupta K.   +5 more
europepmc   +1 more source

Targeting Bruton's Tyrosine Kinase (BTK) in Autoimmunity: Achievements, Opportunities and Challenges. [PDF]

Drug Des Devel Ther
Torke S, Dybowski S, Weber MS.
europepmc   +1 more source

RET receptor tyrosine kinase architecture, assemblies, and activation. [PDF]

Endocr Relat Cancer
Zol-Hanlon M, McDonald NQ.
europepmc   +1 more source

Entomopathogenic fungi as microbial platforms for tyrosine kinase-oriented inhibitor discovery. [PDF]

Appl Microbiol Biotechnol
Chigozie VU, Ogunwa KI, Osuafor NG, Nduwimana LL, Oraekei DI.   +4 more
europepmc   +1 more source

Mutation type, tyrosine kinase function in normal cell and tyrosine kinase inhibitor activity in cancers. [PDF]

Sci Rep
Vanacker H, Cassier PA, Dufresne A, Pérol M, Verlingue L, Swalduz A, Vinceneux A, Attignon V, Brahmi M, Tredan O, Tirode F, Blay J-.   +11 more
europepmc   +1 more source

Bruton Tyrosine Kinase Inhibitors in Immune-Mediated Skin Diseases: Current Evidence and Future Directions. [PDF]

Int J Mol Sci
Wang Z, He J, Zhang T, Peng J, Xie L, Li B, Shan C, Zhang L, Zhao Z.   +8 more
europepmc   +1 more source

Targeting Bruton's Tyrosine Kinase in CLL: Selectivity, Resistance Mechanisms, and Emerging Therapeutic Strategies. [PDF]

Cells
Bravo E, Pastrana CC, Lamkin EN, Ciurko K, Taylor J.   +4 more
europepmc   +1 more source

Inhibition of VEGFR1 Tyrosine Kinase Signaling Attenuates Development of Lung Emphysema by Recruiting Monocyte-derived Macrophages. [PDF]

In Vivo
Akinaga S, Ito Y, Osada M, Yamashita A, Yamazaki T, Hokama S, Hosono K, Kamata M, Shibuya M, Asari Y, Maruhashi T, Amano H.   +11 more
europepmc   +1 more source